| [1] |
Skolarikos A, Jung H, Neisius A, et al. EAU Guidelines on urolithiasis [EB/OL].[2024-04-08].
URL
|
| [2] |
Wang K, Ge J, Han W, et al. Risk factors for kidney stone disease recurrence: a comprehensive meta-analysis[J]. BMC Urol, 2022, 22(1): 62.
|
| [3] |
Forbes CM, McCoy AB, Hsi RS. Clinician versus nomogram predicted estimates of kidney stone recurrence risk[J]. J Endourol, 2021, 35(6): 847-852.
|
| [4] |
Cicerello E. Uric acid nephrolithiasis: an update[J]. Urologia, 2018, 85(3): 93-98.
|
| [5] |
Tran TVM, Maalouf NM. Uric acid stone disease: lessons from recent human physiologic studies[J]. Curr Opin Nephrol Hypertens, 2020, 29(4): 407-413.
|
| [6] |
Chen HW, Chen YC, Lee JT, et al. Prediction of the uric acid component in nephrolithiasis using simple clinical information about metabolic disorder and obesity: a machine learning-based model[J]. Nutrients, 2022, 14(9): 1829.
|
| [7] |
Wang Z, Zhang Y, Zhang J, et al. Recent advances on the mechanisms of kidney stone formation (Review)[J]. Int J Mol Med. 2021, 48(2): 149.
|
| [8] |
Schwaderer AL, Raina R, Khare A, et al. Comparison of risk factors for pediatric kidney stone formation: the effects of sex[J]. Front Pediatr, 2019, 7: 32.
|
| [9] |
Sorokin I, Mamoulakis C, Miyazawa K, et al. Epidemiology of stone disease across the world[J]. World J Urol, 2017, 35(9): 1301-1320.
|
| [10] |
Bargagli M, Ferraro PM, Vittori M, et al. Calcium and vitamin D supplementation and their association with kidney stone disease: a narrative review[J]. Nutrients, 2021, 13(12): 4363.
|
| [11] |
Wagner CA. Etiopathogenic factors of urolithiasis[J]. Arch Esp Urol, 2021, 74(1): 16-23.
|
| [12] |
Zeng G, Zhu W, Robertson WG, et al. International Alliance of Urolithiasis (IAU) Guidelines on the metabolic evaluation and medical management of urolithiasis[J]. Urolithiasis, 2022, 51(1):4.
|
| [13] |
Trinchieri A, Montanari E. Biochemical and dietary factors of uric acid stone formation[J]. Urolithiasis, 2018, 46(2): 167-172.
|
| [14] |
Espinosa-Ortiz EJ, Eisner BH, Lange D, et al. Current insights into the mechanisms and management of infection stones[J]. Nat Rev Urol, 2019, 16(1): 35-53.
|
| [15] |
Choy SH, Nyanatay SA, Sothilingam S, et al. Cardiovascular risk factors, ethnicity and infection stone are independent factors associated with reduced renal function in renal stone formers[J]. PLoS One, 2022, 17(4): e0265510.
|
| [16] |
Williams JC Jr, Gambaro G, Rodgers A, et al. Urine and stone analysis for the investigation of the renal stone former: a consensus conference[J]. Urolithiasis, 2021, 49(1): 1-16.
|
| [17] |
Borofsky MS, Handa RK, Evan AP, et al. In vivo renal tubule pH in stone-forming human kidneys[J]. J Endourol, 2020, 34(2): 203-208.
|
| [18] |
Kim JC, Cho KS, Kim DK, et al. Predictors of uric acid stones: mean stone density, stone heterogeneity index, and variation coefficient of stone density by single-energy non-contrast computed tomography and urinary pH[J]. J Clin Med, 2019, 8(2): 243.
|
| [19] |
Nourian A, Ghiraldi E, Friedlander JI. Dual-energy CT for urinary stone evaluation[J]. Curr Urol Rep, 2020, 22(1): 1.
|
| [20] |
Appel E, Thomas C, Steuwe A, et al. Evaluation of split-filter dual-energy CT for characterization of urinary stones[J]. Br J Radiol, 2021, 94(1127): 20210084.
|
| [21] |
Carbone A, Al Salhi Y, Tasca A, et al. Obesity and kidney stone disease: a systematic review[J]. Ital J Urol Nephrol, 2018, 70(4): 393-400.
|
| [22] |
Wollin DA, Skolarikos A, Preminger GM. Obesity and metabolic stone disease[J]. Curr Opin Urol, 2017, 27(5): 422-427.
|
| [23] |
Prasanchaimontri P, Monga M. Predictive factors for kidney stone recurrence in type 2 diabetes mellitus[J]. Urology, 2020, 143: 85-90.
|
| [24] |
Kim S, Chang Y, Jung HS, et al. Glycemic status, insulin resistance, and the risk of nephrolithiasis: a cohort study[J]. Am J Kidney Dis, 2020, 76(5): 658-668.e1.
|